190 related articles for article (PubMed ID: 9333658)
1. [Angiogenesis and inhibition of angiogenesis in the eye].
Cursiefen C; Schönherr U
Klin Monbl Augenheilkd; 1997 Jun; 210(6):341-51. PubMed ID: 9333658
[TBL] [Abstract][Full Text] [Related]
2. [Molecular mechanisms of vasculogenesis and angiogenesis. What regulates vascular growth?].
Joussen AM; Kirchhof B; Gottstein C
Ophthalmologe; 2003 Apr; 100(4):284-91. PubMed ID: 12682760
[TBL] [Abstract][Full Text] [Related]
3. New concepts in pathogenesis and treatment of diabetic retinopathy.
Spranger J; Pfeiffer AF
Exp Clin Endocrinol Diabetes; 2001; 109 Suppl 2():S438-50. PubMed ID: 11460590
[TBL] [Abstract][Full Text] [Related]
4. Role of the vascular endothelial growth factor isoforms in retinal angiogenesis and DiGeorge syndrome.
Stalmans I
Verh K Acad Geneeskd Belg; 2005; 67(4):229-76. PubMed ID: 16334858
[TBL] [Abstract][Full Text] [Related]
5. Vascular endothelial growth factor and retinal neovascularisation: a new therapeutic approach for diabetic retinopathy.
Favard C; Ortega N; Bayard F; Plouet J
Diabetes Metab; 1996 Jul; 22(4):268-73. PubMed ID: 8767174
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of vascular endothelial growth factor (VEGF) as a novel approach for cancer therapy.
Wood JM
Medicina (B Aires); 2000; 60 Suppl 2():41-7. PubMed ID: 11188930
[TBL] [Abstract][Full Text] [Related]
7. Vascular endothelial growth factor. 20th-century mechanisms, 21st-century therapies.
Aiello LP
Invest Ophthalmol Vis Sci; 1997 Aug; 38(9):1647-52. PubMed ID: 9286253
[No Abstract] [Full Text] [Related]
8. The contribution of proangiogenic factors to the progression of malignant disease: role of vascular endothelial growth factor and its receptors.
Neufeld G; Kessler O; Vadasz Z; Gluzman-Poltorak Z
Surg Oncol Clin N Am; 2001 Apr; 10(2):339-56, ix. PubMed ID: 11382591
[TBL] [Abstract][Full Text] [Related]
9. Growth factors and diabetic retinopathy.
Paques M; Massin P; Gaudric A
Diabetes Metab; 1997 Apr; 23(2):125-30. PubMed ID: 9137900
[TBL] [Abstract][Full Text] [Related]
10. Lymphatic versus blood vascular endothelial growth factors and receptors in humans.
Partanen TA; Paavonen K
Microsc Res Tech; 2001 Oct; 55(2):108-21. PubMed ID: 11596156
[TBL] [Abstract][Full Text] [Related]
11. [Angiogenesis and its regulation].
Iwaguchi T
Gan To Kagaku Ryoho; 1993 Jan; 20(1):1-9. PubMed ID: 7678486
[TBL] [Abstract][Full Text] [Related]
12. Plasma VEGF and soluble VEGF receptor FLT-1 in proliferative retinopathy: relationship to endothelial dysfunction and laser treatment.
Lip PL; Belgore F; Blann AD; Hope-Ross MW; Gibson JM; Lip GY
Invest Ophthalmol Vis Sci; 2000 Jul; 41(8):2115-9. PubMed ID: 10892852
[TBL] [Abstract][Full Text] [Related]
13. Ocular neovascularization: a valuable model system.
Campochiaro PA; Hackett SF
Oncogene; 2003 Sep; 22(42):6537-48. PubMed ID: 14528278
[TBL] [Abstract][Full Text] [Related]
14. [VEGF, anti-vEGF and diseases].
Corvol P
Bull Acad Natl Med; 2008 Feb; 192(2):289-300; discussion 300-2. PubMed ID: 18819684
[TBL] [Abstract][Full Text] [Related]
15. Expression of vascular endothelial growth factor (VEGF) and VEGF receptors in tumor angiogenesis and malignancies.
Pradeep CR; Sunila ES; Kuttan G
Integr Cancer Ther; 2005 Dec; 4(4):315-21. PubMed ID: 16282508
[TBL] [Abstract][Full Text] [Related]
16. [Diabetic retinopathy--the mechanisms of the ocular neovascularization and the development of anti-angiogenic drugs].
Kuroki M; Kawakami M
Nihon Rinsho; 1999 Mar; 57(3):584-9. PubMed ID: 10199138
[TBL] [Abstract][Full Text] [Related]
17. A novel in vitro assay for human angiogenesis.
Brown KJ; Maynes SF; Bezos A; Maguire DJ; Ford MD; Parish CR
Lab Invest; 1996 Oct; 75(4):539-55. PubMed ID: 8874385
[TBL] [Abstract][Full Text] [Related]
18. [Angioproliferative retinal disease caused by ischemia].
Agostini HT; Hansen LL
Ophthalmologe; 2003 May; 100(5):371-7. PubMed ID: 12748802
[TBL] [Abstract][Full Text] [Related]
19. [Eye and pathologic angiogenesis].
Ishibashi T
Fukuoka Igaku Zasshi; 2000 Nov; 91(11):277-83. PubMed ID: 11187718
[No Abstract] [Full Text] [Related]
20. Vascular endothelial growth factor, interleukin 8, platelet-derived endothelial cell growth factor, and basic fibroblast growth factor promote angiogenesis and metastasis in human melanoma xenografts.
Rofstad EK; Halsør EF
Cancer Res; 2000 Sep; 60(17):4932-8. PubMed ID: 10987309
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
